Document is current
Any future updates will be listed below
-
Authors
Suresh, Sevanthy
Venkatesan, Vigneshwaran
Azhagiri, Manoj Kumar K.
Mahalingam, Gokulnath
Chandraprabha, Prathibha Babu
Murugesan, Mohankumar K.
Kumar, Sanjay
Thangavel, Saravanabhavan https://orcid.org/0000-0001-6760-4106
Marepally, Srujan https://orcid.org/0000-0002-2451-3359
-
Funding
Funding for this research was provided by:
Department of Biotechnology, Ministry of Science and Technology, India (BT/PR26901/MED/31/377/2017, BT/PR31616/MED/31/408/2019, BT/PR38267/GET/119/348/2020, BT/PR45683/MED/31/465/2022)
- License Information
-
More Information
Article History
Received: 17 March 2025
Accepted: 18 June 2025
First Online: 1 July 2025
Declarations
:
: The title of study “In vivo efficacy and safety studies of CSCR-ST04, the gene edited autologous hematopoietic stem cells for the gene therapy of β-hemoglobinopathies”. This study was approved by the IRB committee of the Christian Medical College Vellore (Approval number: 11807) dated: 30.01.2019. The study titled “Therapeutic applications of extracellular vesicles-derived from 3D-cultured human Wharton’s Jelly Mesenchymal stromal cells (hWJ-MSCs)”. was approved by the IRB committee of Christian Medical College, Vellore (Approval Number: 14495), dated 23.02.2022.
: Not applicable.
: The authors declare that they have no competing interests.
